Notably, resveratrol has been reported to modulate the TGF-β pathway in RA models,[37] raising the intriguing possibility that its therapeutic effects may involve miR-130a-3p-mediated mechanisms. The gene discussed is TGFB1; the disease is rheumatoid arthritis.